Small Molecules News and Research

RSS
ScinoPharm receives Potent Compound Safety Certification from SafeBridge Consultants

ScinoPharm receives Potent Compound Safety Certification from SafeBridge Consultants

Unique life science-focused application for social media site launched

Unique life science-focused application for social media site launched

New mathematical model may hasten drug development for Parkinson's Disease

New mathematical model may hasten drug development for Parkinson's Disease

Anacor Pharmaceuticals commences patient dosing in AN3365 Phase I clinical study

Anacor Pharmaceuticals commences patient dosing in AN3365 Phase I clinical study

AACR-NCI-EORTC conference highlights major expansion in cancer drug pipeline

AACR-NCI-EORTC conference highlights major expansion in cancer drug pipeline

Agilent Technologies acquires MassCode Tag technology from Eurofins MWG Operon

Agilent Technologies acquires MassCode Tag technology from Eurofins MWG Operon

Fate Therapeutics announces the completion of $30 million Series B financing

Fate Therapeutics announces the completion of $30 million Series B financing

CSHL solves the structure of the zinc-bound ATD domain of the NMDA receptor NR2B subunit

CSHL solves the structure of the zinc-bound ATD domain of the NMDA receptor NR2B subunit

Review of Mersana Therapeutics's lead compound, XMT-1001 to be published

Review of Mersana Therapeutics's lead compound, XMT-1001 to be published

Stapled Peptides directly inhibit the Notch transcription factor complex

Stapled Peptides directly inhibit the Notch transcription factor complex

Stapled Peptides can inhibit key intracellular biological targets, says new research

Stapled Peptides can inhibit key intracellular biological targets, says new research

Scientists find way to disarm "undruggable" protein; discovery lays foundation for new kind of cancer therapy

Scientists find way to disarm "undruggable" protein; discovery lays foundation for new kind of cancer therapy

NIH awards $6.8 million subcontract to Kineta to develop vaccine immune boosters

NIH awards $6.8 million subcontract to Kineta to develop vaccine immune boosters

Enavail obtains an exclusive license for a portfolio of particle engineering technologies

Enavail obtains an exclusive license for a portfolio of particle engineering technologies

New imagining technique may yield better antiviral and anti-cancer drugs

New imagining technique may yield better antiviral and anti-cancer drugs

Researchers find compound that reverses type 1 myotonic dystrophy

Researchers find compound that reverses type 1 myotonic dystrophy

NIH grant to develop a new method for rapidly screening blood samples for biomarkers

NIH grant to develop a new method for rapidly screening blood samples for biomarkers

Researchers develop new molecular tools to investigate Alzheimer's disease

Researchers develop new molecular tools to investigate Alzheimer's disease

Nuevolution receives milestone payment from Merck

Nuevolution receives milestone payment from Merck

NCI awards $4.8M for project to measure all the proteins in the human body

NCI awards $4.8M for project to measure all the proteins in the human body

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.